cell therapy manufacturing

https://www.bms.com/life-and-science/news-and-perspectives/redefining-biologics-cell-therapy-manufacturing-at-devens.html Redefining biologics & cell therapy manufacturing at Devens – Bristol Myers Squibb Jan 23, 2026 - Discover how BMS’ Devens site is using AI, automation, and advanced digital technologies to redefine scale, speed and sustainability in biologics and cell... cell therapy manufacturing bristol myers squibb redefining biologics devens https://www.outsourcedpharma.com/doc/cellular-origins-advances-automation-scalable-cell-therapy-manufacturing-collaboration-immatics-0001 Cellular Origins Advances Automation For Scalable Cell Therapy Manufacturing In Collaboration With... Cellular Origins, enabling the manufacturing of cell therapies at scale, today announced a collaboration with Immatics a late-stage clinical biopharmaceutical... cell therapy manufacturing collaboration with cellular origins advances https://www.biopharmadive.com/spons/selecting-the-optimal-cell-therapy-manufacturing-platform/812042/ Selecting the optimal cell therapy manufacturing platform | BioPharma Dive Navigating modular vs. integrated platforms—find the best path for your cell therapy program. cell therapy manufacturing biopharma dive selecting optimal platform https://medcloudinsider.1105cms01.com/blogs/medcloud-minute/2026/03/sartorius-launches-platform.aspx Sartorius Launches Platform to Improve Cell Therapy Manufacturing Efficiency -- MedCloudInsider New system is designed to streamline production workflows and support scalability in advanced therapies. cell therapy manufacturing sartorius launches platform improve https://greenelephantbiotech.com/blog/innovative-partnership-revolutionizes-cell-therapy-manufacturing-by-introducing-archimedes-one-for-enabling-scalable-automated-adherent-cell-culture/ Innovative partnership revolutionizes cell therapy manufacturing by introducing Archimedes® One for... Gießen and Ingelfingen, Germany – 17.03.2026. Green Elephant Biotech announced the introduction of the Archimedes® One — Dynamic Adherent Bioreactor, a new cell therapy manufacturing innovative partnership introducing one https://webinars.endpoints.news/strategies-for-building-a-cell-therapy-manufacturing-facility/ Strategies for building a cell therapy manufacturing facility - Endpoints Webinars Building an advanced therapeutic manufacturing facility is complex and highly customized. In this webinar co-sponsored by Precision ADVANCE and Project Farma,... cell therapy manufacturing strategies building facility endpoints https://www.regmednet.com/cell-therapy-weekly-fujifilm-to-pump-jp%c2%a510-billion-into-contract-manufacturing/ Cell therapy weekly: Fujifilm to pump JP¥10 billion into contract manufacturing - RegMedNet Jul 11, 2020 - This week: DiscGenics spinal cord therapy passes first-in-human safety review and research uncovers why checkpoint blockade therapies succeed or fail. Editors... cell therapy contract manufacturing weekly fujifilm pump https://oxb.com/viral-vectors/adeno-associated-virus-aav/ AAV Manufacturing Services For Cell And Gene Therapy | OXB Apr 8, 2026 - Accelerate AAV Manufacturing With OXB’s High-Performance Platform, Delivering GMP Supply In As Little As 7 Months With High Titres And Full Capsids. cell and gene therapy manufacturing services aav oxb https://info.formbio.com/de-risk-cell-gene-therapy-manufacturing De-Risk Cell & Gene Therapy Manufacturing Detect risk early, maintain lot-to-lot consistency, and defend product quality from discovery through commercial manufacturing. gene therapy manufacturing de risk cell https://www.regmednet.com/webinars/gmp-manufacturing-of-quality-ancillary-reagents-for-cell-and-gene-therapy_biolegend/ GMP manufacturing of quality ancillary reagents for cell and gene therapy - RegMedNet Oct 7, 2024 - Cell and gene therapy manufacturers face challenges to achieving quality, consistency, and safety in the final product, mandating risk-based management of... cell and gene therapy gmp manufacturing ancillary reagents https://www.biospace.com/drug-delivery/cell-and-gene-therapy-manufacturing-market-to-skyrocket-to-146b-by-2032 Cell and Gene Therapy Manufacturing Market To Skyrocket to $146B by 2032 - BioSpace Mar 10, 2026 - Analysts expect the market for manufacturing cell and gene therapies, worth less than $20 billion in 2024, to expand rapidly as approvals drive higher volumes... cell and gene therapy manufacturing market skyrocket biospace https://www.scinus.com/ Scinus Cell Expansion | Scalable Cell Therapy Manufacturing Scinus provides an automated scalable cell expansion system designed for controlled and reproducible cell culture in advanced cell therapy manufacturing. scinus cell expansion scalable therapy manufacturing https://ipeace.com/en/ Cell and Gene Therapy Manufacturing, cGMP iPSCs | CDMO | I Peace, Inc. Jan 9, 2025 - I Peace is a cell and gene therapy CDMO specializing in iPSC-derived cell products. We provide cGMP iPSC manufacturing service and personal iPSC banking... cell and gene therapy manufacturing https://www.kytopen.com/ Kytopen - The Future in Cell Therapy Discovery and Manufacturing Oct 20, 2025 - Kytopen is accelerating access to the next generation of cell therapies through scalable genome engineering by solving manufacturing problems at discovery the future cell therapy discovery manufacturing https://www.precedenceresearch.com/press-release/automation-digitization-and-robotics-in-cell-and-gene-therapy-manufacturing-market Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market Forecast and... The global global automation, digitization and robotics in cell and gene therapy manufacturing market revenue reached USD 950.00 million in 2025 and is... gene therapy manufacturing market forecast automation digitization robotics https://www.genengnews.com/multimedia/webinars/commercializing-autologous-cell-therapy-bridging-clinical-and-large-scale-manufacturing/ Commercializing Autologous Cell Therapy: Bridging Clinical and Large-Scale Manufacturing Mar 30, 2026 - In this GEN webinar, experts in cell and gene therapy manufacturing will examine the drivers behind the growing disconnect between clinical success and... autologous cell therapy large scale bridging clinical manufacturing

Robuta